Medullary breast carcinoma vs. poorly differentiated ductal carcinoma: An immunohistochemical study with keratin 19 and oestrogen receptor staining

Histopathology

Volumn 29, Issue 3, 1996, Pages 241-245

  Jensen, M L ^a,c   Kiaer H ^b   Melsen, F ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b SVENDBORG HOSPITAL   (Denmark)

^c University Institute of Pathology Arhus   (Denmark)

Author keywords

Breast carcinoma; Ductal carcinoma; Keratin 19; Medullary carcinoma; Oestrogen receptor

Indexed keywords

ESTROGEN RECEPTOR; KERATIN;

ARTICLE; BREAST CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; PRIORITY JOURNAL;

EID: 0029745555     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1996.tb01397.x     Document Type: Article

References (17)

1. Ridolli RL, Rosen PP, Port A, Kinne D, Mike V. Medullary carcinoma of the breast. Cancer 1977: 40; 1365-1385.
2. Pedersen L, Zedeler K, Holck S, Schiodt T, Mouridsen HT. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Br. J. Cancer 1991: 63; 591-595.
3. Rigaud C, Theobald S, Badreddine J, Barlier C, Delobelle A. Gentile A, Jacquemier J, Maisongrosse V, Peffault de Latour M, Trojani M, Zafrani B. Medullary carcinoma of the breast. A multicentre study of its diagnostic consistency. Arch. Pathol. Lab. Med. 1993: 117; 1005-1008.
4. Gaffey MJ, Mills SE, Frierson HF, Zarbo RJ, Boyd JC, Simpson JF, Weiss LM. Medullary carcinoma of the breast: Interobserver variability in histopathologic diagnosis. Modern Pathology 1995: 8; 31-38.
5. Larsimont D, Lespagnard L, Degeyter M, Heimann R. Medullary carcinoma of the breast: a tumour lacking keratin 19. Histopathology 1994: 24; 549-552.
6. Fisher ER, Kenny JP, Sass R, Dimitrov NV, Siderits RH, Fisher BF. NSABP Collaborators. Medullary cancer of the breast revisited. Breast Cancer Research and Treatment 1990: 16; 215-229.
7. Ellis IO, Galea M, Broughton N, Locker A, Blamey RW, Elston CW. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992: 20; 479-489.
8. Pedersen L, Zedeler K, Holck S, Schiodt T, Mouridsen HT. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer. Eur. J. Cancer 1995: 31A; 2289-2295.
9. Bartek J, Taylor-Papadimitriou J, Miller N, Millis R. Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours, Int. J. Cancer 1985: 36; 299-306.
10. Tavassoli FA. In Pathology of the breast. Toronto: Appleton & Lange. 1992: 336-339.
11. Rubens JR, Lewandrowski KB, Kopans DB, Koerner FC, Hall DA, McCarthy KA. Medullary carcinoma of the breast. Arch. Surg. 1990: 125; 601-604.
12. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, Travagli JP, Gadenne C, Friedman S. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988: 61; 2503-2510.
13. Wargotz ES, Silverberg SG. Medullary carcinoma of the breast: A clinicopathological study with appraisal of current diagnostic criteria. Hum. Pathol. 1988: 19; 1340-1346.
14. Dalal P, Shousha S. Keratin 19 in paraffin sections of medullary carcinoma and other benign and malignant breast lesions. Modern Pathology 1995: 8; 413-416.
15. Pertschuk LP, Kim DS, Nayer K, Feldman JG, Eisenberg KB, Carter AC, Zheng Tian Rong, Thelmo WL, Fleisher J, Greene GL. Immunocytochemical oestrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Cancer 1990: 66; 1663-1670.
16. Reiner A, Reiner G, Spona J, Schemper M, Holzner JH. Histopathologic characterization of human breast cancer in correlation with oestrogen receptor status. Cancer 1988: 61; 1149-1154.
17. Ponsky JL, Gliga L, Reynolds S. Medullary carcinoma of the breast: an association with negative hormonal receptors. Journal of Surgical Oncology 1984: 25; 76-78.